Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence-Based Expert Review.

International forum of allergy & rhinology·2026

Same author

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

The New England journal of medicine·2026

Same author

Modified Rapid Needs Assessments in Nebraska (USA) Following the 2024 Arbor Day Tornado.

Prehospital and disaster medicine·2026

Same author

A Plasmode Simulation-Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information-Rich Subsets.

Pharmacoepidemiology and drug safety·2026

Same author

Automated Extraction of Cancer Registry Data from Pathology Reports: Comparing LLM-Based and Ontology-Driven NLP Platforms.

medRxiv : the preprint server for health sciences·2026

Same author

A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data.

Pharmacoepidemiology and drug safety·2026

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

Protocol for Data Collection and Analysis Applied to Automated Facial Expression Analysis Technology and Temporal Analysis for Sensory Evaluation

Protocol for Data Collection and Analysis Applied to Automated Facial Expression Analysis Technology and Temporal Analysis for Sensory Evaluation

Published on: August 26, 2016

Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network Analyzer.

Taxiarchis Botsis¹, John Scott¹, Ravi Goud¹

¹Office of Biostatistics and Epidemiology, CBER, FDA, Rockville, MD, USA.

Studies in Health Technology and Informatics

|August 28, 2014

Summary

This summary is machine-generated.

We developed a new network analysis tool, AENA, to process big data from adverse event reports. This method effectively identifies safety signals in medical product data, improving drug safety surveillance.

More Related Videos

Design and Analysis for Fall Detection System Simplification

Design and Analysis for Fall Detection System Simplification

Published on: April 6, 2020

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: Apr 25, 2026

Protocol for Data Collection and Analysis Applied to Automated Facial Expression Analysis Technology and Temporal Analysis for Sensory Evaluation

Protocol for Data Collection and Analysis Applied to Automated Facial Expression Analysis Technology and Temporal Analysis for Sensory Evaluation

Published on: August 26, 2016

Design and Analysis for Fall Detection System Simplification

Design and Analysis for Fall Detection System Simplification

Published on: April 6, 2020

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

Pharmacovigilance
Network Analysis
Big Data Analytics

Background:

Spontaneous reporting systems, like the US Vaccine Adverse Event Reporting System (VAERS), generate large datasets for medical product safety reviews.
Traditional statistical methods are often inadequate for analyzing the complex "big data" within these systems.

Purpose of the Study:

To develop novel network analysis approaches and a dedicated tool, the FDA Adverse Event Network Analyzer (AENA), for extracting meaningful information from adverse event report data.
To enhance the detection of potential safety signals in medical products.

Main Methods:

Development of the FDA Adverse Event Network Analyzer (AENA).
Implementation of three novel network analysis techniques: a co-occurring triplet weighting scheme, an islands algorithm-inspired visualization layout, and a network growth methodology for outlier detection.
Validation using historical data of Intussusception (IS) following RotaShield vaccine (RV) administration in 1999.

Main Results:

The developed network analysis approaches and AENA were effective in processing and analyzing complex adverse event data.
The historical signal of Intussusception (IS) after RotaShield vaccine (RV) administration was successfully explored and verified using the new methods.
Demonstrated the capability of AENA in pattern recognition within medical product safety data.

Conclusions:

The FDA Adverse Event Network Analyzer (AENA) and its associated network analysis methodologies provide a powerful tool for pattern recognition in medical product safety.
These novel approaches offer a viable solution for analyzing "big data" from spontaneous reporting systems, improving the efficiency and effectiveness of pharmacovigilance.
Supports the broader application of AENA in analyzing diverse clinical datasets for safety and pattern identification.